Cargando…

Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models

We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozza, Matthias, Green, Edward W., Espinet, Elisa, De Roia, Alice, Klein, Corinna, Vogel, Vanessa, Offringa, Rienk, Williams, James A., Sprick, Martin, Harbottle, Richard P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218229/
https://www.ncbi.nlm.nih.gov/pubmed/32420409
http://dx.doi.org/10.1016/j.omtm.2020.04.017
_version_ 1783532755961774080
author Bozza, Matthias
Green, Edward W.
Espinet, Elisa
De Roia, Alice
Klein, Corinna
Vogel, Vanessa
Offringa, Rienk
Williams, James A.
Sprick, Martin
Harbottle, Richard P.
author_facet Bozza, Matthias
Green, Edward W.
Espinet, Elisa
De Roia, Alice
Klein, Corinna
Vogel, Vanessa
Offringa, Rienk
Williams, James A.
Sprick, Martin
Harbottle, Richard P.
author_sort Bozza, Matthias
collection PubMed
description We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalian S/MAR element can provide persistent mitotic stability over hundreds of cell divisions, resisting epigenetic silencing and thereby allowing sustained transgene expression. The composition of the original S/MAR vectors does present some inherent limitations that can provoke cellular toxicity. Herein, we present a new system, the nano-S/MAR, which drives higher transgene expression and has improved efficiency of establishment, due to the minimal impact on cellular processes and perturbation of the endogenous transcriptome. We show that these features enable the hitherto challenging genetic modification of patient-derived cells to stably restore the tumor suppressor gene SMAD4 to a patient-derived SMAD4 knockout pancreatic cancer line. Nano-S/MAR modification does not alter the molecular or phenotypic integrity of the patient-derived cells in cell culture and xenograft mouse models. In conclusion, we show that these DNA vectors can be used to persistently modify a range of cells, providing sustained transgene expression while avoiding the risks of insertional mutagenesis and other vector-mediated toxicity.
format Online
Article
Text
id pubmed-7218229
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-72182292020-05-15 Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models Bozza, Matthias Green, Edward W. Espinet, Elisa De Roia, Alice Klein, Corinna Vogel, Vanessa Offringa, Rienk Williams, James A. Sprick, Martin Harbottle, Richard P. Mol Ther Methods Clin Dev Article We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalian S/MAR element can provide persistent mitotic stability over hundreds of cell divisions, resisting epigenetic silencing and thereby allowing sustained transgene expression. The composition of the original S/MAR vectors does present some inherent limitations that can provoke cellular toxicity. Herein, we present a new system, the nano-S/MAR, which drives higher transgene expression and has improved efficiency of establishment, due to the minimal impact on cellular processes and perturbation of the endogenous transcriptome. We show that these features enable the hitherto challenging genetic modification of patient-derived cells to stably restore the tumor suppressor gene SMAD4 to a patient-derived SMAD4 knockout pancreatic cancer line. Nano-S/MAR modification does not alter the molecular or phenotypic integrity of the patient-derived cells in cell culture and xenograft mouse models. In conclusion, we show that these DNA vectors can be used to persistently modify a range of cells, providing sustained transgene expression while avoiding the risks of insertional mutagenesis and other vector-mediated toxicity. American Society of Gene & Cell Therapy 2020-04-25 /pmc/articles/PMC7218229/ /pubmed/32420409 http://dx.doi.org/10.1016/j.omtm.2020.04.017 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bozza, Matthias
Green, Edward W.
Espinet, Elisa
De Roia, Alice
Klein, Corinna
Vogel, Vanessa
Offringa, Rienk
Williams, James A.
Sprick, Martin
Harbottle, Richard P.
Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title_full Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title_fullStr Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title_full_unstemmed Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title_short Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
title_sort novel non-integrating dna nano-s/mar vectors restore gene function in isogenic patient-derived pancreatic tumor models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218229/
https://www.ncbi.nlm.nih.gov/pubmed/32420409
http://dx.doi.org/10.1016/j.omtm.2020.04.017
work_keys_str_mv AT bozzamatthias novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT greenedwardw novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT espinetelisa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT deroiaalice novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT kleincorinna novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT vogelvanessa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT offringarienk novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT williamsjamesa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT sprickmartin novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels
AT harbottlerichardp novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels